{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:54:14Z","timestamp":1793044454349,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00066-018-1385-0","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T07:08:47Z","timestamp":1540278527000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Repeated SBRT for in- and out-of-field recurrences in the liver","Wiederholte SBRT bei In- und Out-of-field Rezidiven der Leber"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-252X","authenticated-orcid":false,"given":"Eleni","family":"Gkika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iosif","family":"Strouthos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kirste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Adebahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schultheiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Bettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Brass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Maruschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes Philipp","family":"Neeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Arke","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Baptist","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bpg.2016.06.003","volume":"30","author":"A Mendez Romero","year":"2016","unstructured":"Mendez Romero A, de Man RA (2016) Stereotactic body radiation therapy for primary and metastatic liver tumors: from technological evolution to improved patient care. Best Pract Res Clin Gastroenterol 30:603\u2013616","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","volume":"18","author":"N Andratschke","year":"2018","unstructured":"Andratschke N, Alheid H, Allgauer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S, Guckenberger M et al (2018) The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. BMC Cancer 18:283","journal-title":"BMC Cancer"},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RK, Dinniwell RE, Kassam Z, Ringash J, Cummings B et\u00a0al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J\u00a0Clin Oncol 31:1631\u20131639","journal-title":"J Clin Oncol"},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2017.01.013","volume":"123","author":"RJ Klement","year":"2017","unstructured":"Klement RJ, Guckenberger M, Alheid H, Allgauer M, Becker G, Blanck O, Boda-Heggemann J, Brunner T, Duma M, Gerum S et al (2017) Stereotactic body radiotherapy for oligo-metastatic liver disease\u2014influence of pre-treatment chemotherapy and histology on local tumor control. Radiother Oncol 123:227\u2013233","journal-title":"Radiother Oncol"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1186\/s12885-017-3788-1","volume":"17","author":"E Gkika","year":"2017","unstructured":"Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, Fritsch R, Brass V, Nestle U, Grosu AL, Brunner TB (2017) Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. BMC Cancer 17:781","journal-title":"BMC Cancer"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7150\/jca.13032","volume":"6","author":"A Mahadevan","year":"2015","unstructured":"Mahadevan A, Dagoglu N, Mancias J, Raven K, Khwaja K, Tseng JF, Ng K, Enzinger P, Miksad R, Bullock A, Evenson A (2015) Stereotactic body radiotherapy (SBRT) for Intrahepatic and hilar cholangiocarcinoma. J\u00a0Cancer 6:1099\u20131104","journal-title":"J Cancer"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","volume":"34","author":"DR Wahl","year":"2016","unstructured":"Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M (2016) Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma. J\u00a0Clin Oncol 34:452\u2013459","journal-title":"J Clin Oncol"},{"issue":"1","key":"1385_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","volume":"19","author":"KK Herfarth","year":"2001","unstructured":"Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a\u00a0phase I\/II trial. J\u00a0Clin Oncol 19(1):164\u2013170","journal-title":"J Clin Oncol"},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00066-014-0714-1","volume":"190","author":"F Sterzing","year":"2014","unstructured":"Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M (2014) Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on stereotactic radiotherapy. Strahlenther Onkol 190:872\u2013881","journal-title":"Strahlenther Onkol"},{"key":"1385_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijrobp.2015.04.016","volume":"93","author":"J Klein","year":"2015","unstructured":"Klein J, Dawson LA, Jiang H, Kim J, Dinniwell R, Brierley J, Wong R, Lockwood G, Ringash J (2015) Prospective longitudinal assessment of quality of life for liver cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 93:16\u201325","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","volume":"70","author":"A Mendez Romero","year":"2008","unstructured":"Mendez Romero A, Wunderink W, van Os RM, Nowak PJ, Heijmen BJ, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC (2008) Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 70:1447\u20131452","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","volume":"111","author":"S Culleton","year":"2014","unstructured":"Culleton S, Jiang H, Haddad CR, Kim J, Brierley J, Brade A, Ringash J, Dawson LA (2014) Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma. Radiother Oncol 111:412\u2013417","journal-title":"Radiother Oncol"},{"key":"1385_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","volume":"141","author":"M Scorsetti","year":"2015","unstructured":"Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D\u2019Agostino G et al (2015) The challenge of inoperable hepatocellular carcinoma (HCC): results of a\u00a0single-institutional experience on stereotactic body radiation therapy (SBRT). J\u00a0Cancer Res Clin Oncol 141:1301\u20131309","journal-title":"J Cancer Res Clin Oncol"},{"key":"1385_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00066-017-1256-0","volume":"194","author":"E Gkika","year":"2018","unstructured":"Gkika E, Bettinger D, Krafft L, Schultheiss M, Neeff HP, Maruschke L, Schulenburg M, Adebahr S, Kirste S, Nestle U et al (2018) The role of albumin\u2013bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy. Strahlenther Onkol 194:403\u2013413","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1385_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, Jang JW, Smirne C, Kim YW et\u00a0al (2017) The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. J\u00a0Hepatol 66(2):338\u2013346","journal-title":"J Hepatol"},{"key":"1385_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O\u2019Beirne J, Fox R, Skowronska A, Palmer D et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a\u00a0new evidence-based approach-the ALBI grade. J\u00a0Clin Oncol 33:550\u2013558","journal-title":"J Clin Oncol"},{"issue":"8","key":"1385_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RNH Pugh","year":"1973","unstructured":"Pugh RNH, Murray\u2010Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646\u2013649","journal-title":"Br J Surg"},{"key":"1385_CR18","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","volume":"76","author":"CC Pan","year":"2010","unstructured":"Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76:S94\u2013100","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1385_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M et\u00a0al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"issue":"6","key":"1385_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00066-017-1099-8","volume":"193","author":"E Gkika","year":"2017","unstructured":"Gkika E, Adebahr S, Kirste S, Schimek-Jasch T, Wiehle R, Claus R, Wittel U, Nestle U, Baltas D, Grosu AL, Brunner TB (2017) Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer. Strahlenther Onkol 193(6):433\u2013443","journal-title":"Strahlenther Onkol"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","volume":"12","author":"E Gkika","year":"2017","unstructured":"Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R et\u00a0al (2017) Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma. Radiat Oncol 12:116","journal-title":"Radiat Oncol"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","volume":"18","author":"RD Timmerman","year":"2008","unstructured":"Timmerman RD (2008) An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18:215\u2013222","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"1385_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00066-016-1057-x","volume":"192","author":"TB Brunner","year":"2016","unstructured":"Brunner TB, Nestle U, Adebahr S, Gkika E, Wiehle R, Baltas D, Grosu AL (2016) Simultaneous integrated protection: a new concept for high-precision radiation therapy. Strahlenther Onkol 192(2):886\u2013894","journal-title":"Strahlenther Onkol"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.12659","volume":"29","author":"CH Lo","year":"2014","unstructured":"Lo CH, Huang WY, Lin KT, Lin MJ, Lin TP, Jen YM (2014) Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma. J\u00a0Gastroenterol Hepatol 29:1919\u20131925","journal-title":"J Gastroenterol Hepatol"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3857\/roj.2015.33.4.276","volume":"33","author":"SW Seol","year":"2015","unstructured":"Seol SW, Yu JI, Park HC, Lim DH, Oh D, Noh JM, Cho WK, Paik SW (2015) Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma. Radiat Oncol\u00a0J 33:276\u2013283","journal-title":"Radiat Oncol J"},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13014-016-0663-1","volume":"11","author":"Y Huang","year":"2016","unstructured":"Huang Y, Chen SW, Fan CC, Ting LL, Kuo CC, Chiou JF (2016) Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma. Radiat Oncol 11:89","journal-title":"Radiat Oncol"},{"key":"1385_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3349\/ymj.2016.57.1.41","volume":"57","author":"DS Lee","year":"2016","unstructured":"Lee DS, Woo JY, Kim JW, Seong J (2016) Re-irradiation of hepatocellular carcinoma: clinical applicability of deformable image registration. Yonsei Med\u00a0J 57:41\u201349","journal-title":"Yonsei Med J"},{"key":"1385_CR28","first-page":"597","volume":"48","author":"GB Reed","year":"1966","unstructured":"Reed GB, Cox AJ (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597\u2013611","journal-title":"Am J Pathol"},{"key":"1385_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","volume":"53","author":"LA Dawson","year":"2002","unstructured":"Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810\u2013821","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1080\/02841860600936369","volume":"45","author":"LA Dawson","year":"2006","unstructured":"Dawson LA, Eccles C, Craig T (2006) Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45:856\u2013864","journal-title":"Acta Oncol"},{"key":"1385_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0360-3016(94)00471-4","volume":"31","author":"A Jackson","year":"1995","unstructured":"Jackson A, Ten Haken RK, Robertson JM, Kessler ML, Kutcher GJ, Lawrence TS (1995) Analysis of clinical complication data for radiation hepatitis using a\u00a0parallel architecture model. Int J Radiat Oncol Biol Phys 31:883\u2013891","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.semradonc.2017.02.001","volume":"27","author":"EL Pollom","year":"2017","unstructured":"Pollom EL, Chin AL, Diehn M, Loo BW, Chang DT (2017) Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy. Semin Radiat Oncol 27:197\u2013208","journal-title":"Semin Radiat Oncol"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.rpor.2017.03.001","volume":"22","author":"R Michel","year":"2017","unstructured":"Michel R, Francoise I, Laure P, Anouchka M, Guillaume P, Sylvain K (2017) Dose to organ at risk and dose prescription in liver SBRT. Rep Pract Oncol Radiother 22:96\u2013102","journal-title":"Rep Pract Oncol Radiother"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","volume":"30","author":"GG Hanna","year":"2018","unstructured":"Hanna GG, Murray L, Patel R, Jain S, Aitken KL, Franks KN, van As N, Tree A, Hatfield P, Harrow S et\u00a0al (2018) UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol 30:5\u201314","journal-title":"Clin Oncol"},{"key":"1385_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.290","author":"M Miften","year":"2018","unstructured":"Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tom\u00e9 WA, Ten Haken RK, Ohri N, M\u00e9ndez Romero A et al (2018) Radiation dose-volume effects for liver SBRT. Int J Radiat Oncol Biol Phys. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2017.12.290\n                    \n                   (Article in Press)","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13014-018-0969-2","volume":"13","author":"A Mahadevan","year":"2018","unstructured":"Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundararaman S, D\u2019Ambrosio D, Sharma S, Perry D, Kolker J, Davis J (2018) Stereotactic body radiotherapy (SBRT) for liver metastasis\u2014clinical outcomes from the international multi-institutional RSSearch(R) Patient Registry. Radiat Oncol 13:26","journal-title":"Radiat Oncol"},{"key":"1385_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13014-015-0369-9","volume":"10","author":"NH Andratschke","year":"2015","unstructured":"Andratschke NH, Nieder C, Heppt F, Molls M, Zimmermann F (2015) Stereotactic radiation therapy for liver metastases: factors affecting local control and survival. Radiat Oncol 10:69","journal-title":"Radiat Oncol"},{"key":"1385_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijrobp.2017.10.005","volume":"100","author":"I Naqa El","year":"2018","unstructured":"El Naqa I, Johansson A, Owen D, Cuneo K, Cao Y, Matuszak M, Bazzi L, Lawrence TS, Ten Haken RK (2018) Modeling of normal tissue complications using imaging and biomarkers after radiation therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 100:335\u2013343","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","volume":"113","author":"MG Guren","year":"2014","unstructured":"Guren MG, Undseth C, Rekstad BL, Braendengen M, Dueland S, Spindler KL, Glynne-Jones R, Tveit KM (2014) Reirradiation of locally recurrent rectal cancer: a\u00a0systematic review. Radiother Oncol 113:151\u2013157","journal-title":"Radiother Oncol"},{"key":"1385_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/COC.0000000000000338","volume":"41","author":"EM Osborne","year":"2018","unstructured":"Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E et al (2018) Hyperfractionated accelerated reirradiation for patients with recurrent anal cancer previously treated with definitive chemoradiation. Am J Clin Oncol 41:632\u2013637","journal-title":"Am J Clin Oncol"},{"key":"1385_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1748-717X-7-74","volume":"7","author":"CE Lominska","year":"2012","unstructured":"Lominska CE, Unger K, Nasr NM, Haddad N, Gagnon G (2012) Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas. Radiat Oncol 7:74","journal-title":"Radiat Oncol"},{"key":"1385_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7150\/jca.13295","volume":"7","author":"N Dagoglu","year":"2016","unstructured":"Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A (2016) Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer. J\u00a0Cancer 7:283\u2013288","journal-title":"J Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1385-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:03:30Z","timestamp":1571825010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1385-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1385-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"E.\u00a0Gkika, I.\u00a0Strouthos, S.\u00a0Kirste, S.\u00a0Adebahr, M.\u00a0Schultheiss, D.\u00a0Bettinger, R.\u00a0Fritsch, V.\u00a0Brass, L.\u00a0Maruschke, H.P.\u00a0Neeff, S.A.\u00a0Lang, U.\u00a0Nestle, A.-L.\u00a0Grosu and T.B.\u00a0Brunner declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was evaluated by the ethics committee of the University Hospital of Freiburg. Consent to publish was obtained. This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}